GO FUND IT NOW

National Institutes of Health

Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing September 7, 2026.

Funder
National Institutes of Health
Funding
Grant / contract
Deadline
Sep 7, 2026
(38d left)
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) | Go Fund It Now